Chungbuk National University Hospital
Cheongju-si, South Korea
NCT Number: NCT05155072
A Randomized, Open-label, Oral in healthy male volunteers
Looking for future studies?
Notify Me19 year and older
Male
Interventional
Phase 1
Cheongju-si, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
•Clinically significant Medical History
DW1903
DW1903-R1
DW1903-R2
Time frame: up to day 5
Pharmacodynamic Endpoint
Daewon Pharmaceutical Co., Ltd.
Industry
A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics After Oral Administration of DW1903, DW1903-R1 and DW1903-R2 in Healthy Adult Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07378540
Digestive System Diseases, Dysbiosis
Aydin, Turkey (Türkiye)
View Trial DetailsNCT06981819
Digestive System Diseases, Digestive System Neoplasms
Shanghai, China
View Trial DetailsNCT05742568
Digestive System Diseases, Digestive System Neoplasms
Xi'an, Shaanxi, China
View Trial DetailsNCT06576882
Adolescents, Digestive System Diseases
Alexandria, Egypt
View Trial Details